07 novembre 2017 Radioterapia

Raysearch enters into the field of Boron Neutron Capture Therapy

RaySearch and Neutron Therapeutics, Inc., based in Danvers, US, have entered into an agreement regarding treatment planning for boron neutron capture therapy (BNCT), which is a unique type of radiation therapy that enables targeting of cancer at the cellular level.

BNCT uses a two-step process. First, the patient is injected with a tumor-localizing drug containing the non-radioactive isotope boron-10. In the second step, the target area is exposed to a beam of low-energy neutrons, many of which are absorbed by the boron-10. The absorption initiates a reaction in which short-range, high-energy charged particles are emitted. These particles systematically destroy the tumor cells, with minimal damage to adjacent healthy tissue.

As part of this agreement, RayStation’s functionality will be extended to support BNCT planning requirements*. BNCT will be an additional treatment modality in RayStation, alongside the existing options for photon, electron, proton, and carbon ion* therapy. Users of BNCT will have access to the full range of advanced functionality in RayStation, such as atlas-based segmentation, deformable image registration and scripting.

Neutron Therapeutics is developing a complete single-room solution for BNCT, including an accelerator-based neutron source, treatment room equipment, and a dose engine interfaced to a RayStation treatment planning system. The first installation of the system will be at Helsinki University Hospital, and the facility is scheduled to open in 2018.

Theodore Smick, CEO of Neutron Therapeutics, says: “We are glad to have RaySearch as a partner in the effort to create a comprehensive solution and make the benefits of BNCT available to the patients who need it. Clinics that want to adopt this powerful treatment technique will need high-quality, BNCT-specific treatment planning software, which RaySearch can provide.”

Johan Löf, CEO of RaySearch, says: “We are very pleased to extend RayStation’s capabilities to support BNCT and integrate with Neutron Therapeutics technology. BNCT has great potential and I’m excited to explore the clinical benefits and enable the use of this treatment technique in routine hospital workflow.”


About Neutron Therapeutics
Neutron Therapeutics is a medical equipment company that is developing a comprehensive solution for BNCT. The company was founded in 2014, with a mission to apply high-power proton accelerator technology to the challenge of a practical in-hospital neutron source. 


22/05/2018 News

Piattaforma per l’analisi e la comparazione delle immagini di tomosintesi della mammella”: il 28 maggio al CRO l’evento finale di progetto

Si terrà lunedì 28 maggio al CRO – Centro di Riferimento Oncologico di Aviano l’evento di presentazione finale del progetto “Piattaforma per l’analisi e la comparazione delle immag [...]

21/05/2018 News

Strong uptake of RayStation Monte Carlo dose engine among proton therapy centers

13 out of 18 RayStation proton sites in clinical operation are now using the proton Monte Carlo (MC) dose engine, and this just a year after it was released. That according to a survey. “The implementation of th [...]

08/05/2018 Radioterapia


Tecnologie Avanzate è lieta di annunciare che giovedì 3 maggio è stato firmato l'accordo tra lo IEO - Istituto Europeo di Oncologia di Milano e la IBA (Ion Beam Applications, S.A, Euronext) per [...]


20gen2017 | Eventi

RayCare Symposium, Roma 26 gennaio 2017

Tecnologie Avanzate è lieta di comunicare che il 26 gennaio organizza a Roma il primo RayCare Symposium, un incontro destinato a presentare in [...]

24mag2018 | Medicina nucleare

Corso Nazionale AIMN, Bergamo, 24-26 maggio 2018

Tecnologie Avanzate sarà sponsor del Corso Nazionale AIMN che avrà luogo a Bergamo il 24-26 maggio 2018.

Video gallery